
Pharmaceutical grade production
At Cambridge Health™ we operate an advanced peptide manufacturing facility, run to strict pharmaceutical production standards. Our production environment has been designed to support high quality peptide research manufacturing with a strong focus on consistency, sterility, precision and quality control throughout every stage of the process.
Every stage of production is carried out within controlled laboratory conditions by trained technicians using professional clean room protocols and sterile handling procedures.
Our manufacturing operation follows strict quality assurance procedures with extensive batch testing, purity analysis and environmental controls designed to maintain consistency and reliability across production.
The facility environment is modern, highly controlled and purpose built for peptide manufacturing, featuring pharmaceutical grade stainless steel infrastructure, sterile production areas and advanced laboratory technology throughout the entire operation.
At Cambridge Health™ we place strong importance on quality, professional standards and responsible research manufacturing processes.
- GMP aligned productionPharmaceutical grade production environment
- Purity exceeding 99%Every batch independently tested
- Sterile productionClean room controlled manufacturing
- Batch testedFull QA documentation available
Facility & equipment
- Stainless steel peptide synthesis equipment
- Advanced chromatography purification systems
- Sterile vial filling and sealing lines
- Lyophilisation freeze drying technology
- HEPA filtered clean room air systems
- Laboratory analytical testing equipment
- Glass reactor systems and pressure monitored production lines
- Digital environmental monitoring and quality control systems


Our own testing laboratory
Our in-house analytical laboratory supports quality control alongside manufacturing. We use HPLC and LC-MS methods to examine research materials and their composition.

HPLC analysis
High-performance liquid chromatography separates sample components to assess peptide purity and measure peptide content. The amount present and the purity percentage answer different questions and are reported separately.
LC-MS screening
Liquid chromatography with mass spectrometry supports peptide identification and screening for other peptides or degradation products within the scope of the method.
Testing matched to the sample
Blends require component-specific analysis. Additional checks, such as aggregate, residual TFA, endotoxin, microbial or heavy-metal analysis, are distinct tests. Ask our team which analyses are included for your batch.
Batch documentation
Request the Certificate of Analysis for your research material. Review the sample identity, methods, units and results together. A purity result alone does not establish sterility or suitability for human use.
Research use only All products are supplied for laboratory research only. Not for human or animal consumption.